biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > HHHmmmm...

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Aug 15, 2022 5:12pm

427 Views

Post# 34897686

RE:RE:RE:HHHmmmm...

So Aarcor, pof is suggesting that Bioasis has no money and he's surprised that the financing hasn't happened yet.

So I offer some possible reasons for that. Just speculation, mind you.

The thing is, Bioasis appears to still be in business. How can YOU explain that, Aarcor? Under what circumstances could Bioasis still be operating?

Prove, just for once, Aarcor, that you can put a couple of thoughts together and not just run your mouth off.

Go for it. Prove you have a brain.

jd

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages